VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 377 filers reported holding VANECK VECTORS ETF TR in Q3 2017. The put-call ratio across all filers is 1.17 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,418,500 | +39.7% | 350,000 | +56.3% | 0.03% | +35.0% |
| Q2 2023 | $6,744,158 | -82.6% | 223,984 | -81.3% | 0.02% | -83.3% |
| Q1 2023 | $38,820,000 | +1254.5% | 1,200,000 | +1100.0% | 0.12% | +1100.0% |
| Q4 2022 | $2,866,000 | +742.9% | 100,000 | +900.0% | 0.01% | +400.0% |
| Q2 2021 | $340,000 | -96.8% | 10,000 | -98.0% | 0.00% | -96.1% |
| Q4 2018 | $10,545,000 | -9.3% | 500,000 | 0.0% | 0.05% | +2.0% |
| Q4 2017 | $11,620,000 | +1.2% | 500,000 | 0.0% | 0.05% | -2.0% |
| Q3 2017 | $11,480,000 | -50.5% | 500,000 | -52.4% | 0.05% | -60.8% |
| Q2 2017 | $23,184,000 | -3.2% | 1,050,000 | 0.0% | 0.13% | -2.3% |
| Q1 2017 | $23,951,000 | +9.0% | 1,050,000 | 0.0% | 0.13% | -13.6% |
| Q4 2016 | $21,966,000 | +428.4% | 1,050,000 | +600.0% | 0.15% | +450.0% |
| Q2 2016 | $4,157,000 | – | 150,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |